Order Article Reprints

Roudsari NM, Lashgari N-A, Momtaz S, Abaft S, Jamali F, Safaiepour P, Narimisa K, Jackson G, Bishayee A, Rezaei N, et al. Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention. Pharmaceutics. 2021; 13(8):1195. https://doi.org/10.3390/pharmaceutics13081195

Roudsari, Nazanin Momeni, Naser-Aldin Lashgari, Saeideh Momtaz, Shaghayegh Abaft, Fatemeh Jamali, Pardis Safaiepour, Kiyana Narimisa, Gloria Jackson, Anusha Bishayee, Nima Rezaei, and et al. 2021. "Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention" Pharmaceutics 13, no. 8: 1195. https://doi.org/10.3390/pharmaceutics13081195

Roudsari, N. M., Lashgari, N.-A., Momtaz, S., Abaft, S., Jamali, F., Safaiepour, P., Narimisa, K., Jackson, G., Bishayee, A., Rezaei, N., Abdolghaffari, A. H., & Bishayee, A. (2021). Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention. Pharmaceutics, 13(8), 1195. https://doi.org/10.3390/pharmaceutics13081195